Vanberra Signal
Free trial

Collaborations Pharmaceuticals

Curated by Signal

Research and development of therapeutics for multiple rare and infectious diseases

Health Technologycollaborationspharma.com

Overview

Collaborations Pharmaceuticals engaged in research and development of therapeutics for multiple rare and infectious diseases. The company partners with academics or companies to identify and translate early preclinical to clinical stage assets. Its drug pipeline includes CPI-101 for tuberculosis; CPI-201(targets Serine/threonine-protein kinase PAK 1) for Hereditary Neuropathy with Liability to Pressure Palsy (HNPP); CPI-301(targets sodium channel) for rare epilepsy; CPI-401 (targets alpha-7 nicotinic receptor) for Alzheimer's; CPI-501 for Ebola and CPI-601 for Batten disease. All of its drug programs are in the preclinical stage. The company also offers drug discovery services.

Key facts

Founded
2014
Headquarters
Raleigh, United States
Stage
Sign up to view
Industry
Health Technology

Business model

7 products and services
Sign up to view
Commercial model
Sign up to view

Contact

Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • ABAKadabra

    Provider of a behavioral health analytics platform for healthcare providers and teachers

    Health TechnologyVirginia Beach, United States

  • Peaks Curative

    Online platform offering telemedicine services for men health

    Health TechnologyMiami, United States

  • Healthy Contracts

    Provider of contract lifecycle management for healthcare

    Health TechnologyExeter, United States

About Collaborations Pharmaceuticals

What does Collaborations Pharmaceuticals do?

Collaborations Pharmaceuticals engaged in research and development of therapeutics for multiple rare and infectious diseases.

Where is Collaborations Pharmaceuticals headquartered?

Collaborations Pharmaceuticals is headquartered in Raleigh, United States.

When was Collaborations Pharmaceuticals founded?

Collaborations Pharmaceuticals was founded in 2014.

Which sector is Collaborations Pharmaceuticals in?

Collaborations Pharmaceuticals operates in Health Technology.

Who are Collaborations Pharmaceuticals's competitors?

Companies similar to Collaborations Pharmaceuticals include ABAKadabra, Peaks Curative, and Healthy Contracts.